This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday – Avalo Therapeutics (NASDAQ:AVTX), Assembly Biosciences (NASDAQ:ASMB)

Mar 25, 2025
this-clearway-energy-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-tuesday-–-avalo-therapeutics-(nasdaq:avtx),-assembly-biosciences-(nasdaq:asmb)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Deutsche Bank analyst Corinne Blanchard initiated coverage on Clearway Energy, Inc. CWEN with a Buy rating and announced a price target of $38. Clearway Energy shares closed at $29.85 on Monday. See how other analysts view this stock.
  • Stifel analyst Alex Thompson initiated coverage on Crinetics Pharmaceuticals, Inc. CRNX with a Buy rating and announced a price target of $60. Crinetics Pharmaceuticals shares closed at $35.94 on Monday. See how other analysts view this stock.
  • Evercore ISI Group analyst John Pancari initiated coverage on OneMain Holdings, Inc. OMF with an In-Line rating and announced a price target of $58. OneMain shares closed at $52.87 on Monday. See how other analysts view this stock.
  • Jefferies analyst Kambiz Yazdi initiated coverage on Avalo Therapeutics, Inc. AVTX with a Buy rating and announced a price target of $23. Avalo Therapeutics shares closed at $7.63 on Monday. See how other analysts view this stock.
  • Guggenheim analyst Vamil Divan initiated coverage on Assembly Biosciences, Inc. ASMB with a Buy rating and announced a price target of $31. Assembly Biosciences shares closed at $11.12 on Monday.  See how other analysts view this stock.

Considering buying CWEN stock? Here’s what analysts think:

Read This Next:

ASMB Logo

ASMBAssembly Biosciences Inc

$11.614.41%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Edge Rankings

Momentum18.85

Growth

Quality

Value73.35

Price Trend

Short

Medium

Long

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

date

ticker

name

Price Target

Upside/Downside

Recommendation

Firm

Analyst Calendar

Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market’s most accurate analysts.


Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Already a member?Sign in

Benzinga.com on devices

Leave a comment